The CAB meets regularly throughout the year to offer input on the Kentucky Cancer Needs Assessment, Markey’s strategic plan, research priorities and outreach activities.
Physicians and scientists from the UK Markey Cancer Center will share their latest research at the American Society of Clinical Oncology’s annual meeting in Chicago from May 30 to June 3.
UK Markey Cancer Center researchers have identified a mechanism by which a gut hormone contributes to fatty liver disease, offering potential new targets for treating the common condition.
The UK Markey Cancer Center has enrolled its 10,000th patient in the Oncology Research Information Exchange Network (ORIEN) since joining the alliance in 2017.
At the annual gathering of cancer experts, the UK Markey Cancer Center team will present studies with the potential to significantly transform cancer care.
Researchers at UK have introduced a technique that could revolutionize cancer research by providing an accessible way to study how cancer cells adapt to treatments.
Recent research shows that a commercially available decaffeinated coffee product containing a controlled dose of Artemisia annua may have anti-cancer properties.
Researchers focused on analyzing samples from patients diagnosed with colon adenocarcinoma and looking at characteristics that could explain disparities in cancer outcomes in Kentucky.
